ADVERTISEMENT
The patient’s journey: from stability to sudden symptoms
The patient’s medical history included hypertension and long-term treatment for COPD. Her treatment plan included enalapril for blood pressure control and a formoterol inhaler for her respiratory condition. For years, her progress had been relatively good.
But as her lung function began to decline, her pulmonologist decided to adjust her regimen and prescribed a new combination inhaler containing indacaterol and glycopyrronium. This was a standard, evidence-based decision intended to improve her breathing and slow the progression of the disease.
ADVERTISEMENT